IL4 and hemorrhagic cystitis: Recombinant IL-4, quinovic acid glycosides, anakinra, diallyl disulfide and other anti-inflammatory candidates were separately shown to reduce the pathogenesis of hemorrhagic cystitis by inhibition of the expression of these inflammatory cytokines and their receptors12,23,25,26.